- call +1-201-465-4211
- email sales@mrinsights.biz
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.
Scope of the Report:
North America is the largest consumption market of Human Coagulation Factor VIII, with sales market share nearly 46%. And the production market share of Human Coagulation Factor VIII is 58%. The manufacturers of Human Coagulation Factor VIII in North America have big and medium scale.
The second place is Europe, following North America with the sales market share of 36% and the production market share over 28%. Many European players have plants in USA due to rich plasma source. So there are a large number of Human Coagulation Factor VIIIs for import from other regions.
Asia is another important market of Human Coagulation Factor VIII, enjoying 10% production market share and 11% sales market share. Especially in China, the sales and price of Factor VIII are controlled by country, and the price in China is different from other regions.
Main players are from USA and Europe, like Baxter, Bayer, and they have many plants in other regions. China also can supply Human Coagulation Factor VIII, but the products are mainly consumed in China.
Market competition is intense. Baxter, Bayer, CSL, Pfizer, Grifols, etc. are the leaders of the industry, and hold key technologies, with high-end customers, have been formed in the monopoly position in the industry. However, with further expanding market, there will be more manufactures in the future.
The worldwide market for Human Coagulation Factor VIII is expected to grow at a CAGR of roughly 2.8% over the next five years, will reach 8770 million US$ in 2024, from 7440 million US$ in 2019, according to a new study.
This report focuses on the Human Coagulation Factor VIII in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Recombinant Factor VIII
Plasma-derived Factor VIII
Market Segment by Applications, can be divided into
Hemophilia A
Spontanous / Trauma
Surgical
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Coagulation Factor VIII product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Coagulation Factor VIII, with price, sales, revenue and global market share of Human Coagulation Factor VIII in 2017 and 2018.
Chapter 3, the Human Coagulation Factor VIII competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Coagulation Factor VIII breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Human Coagulation Factor VIII market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Human Coagulation Factor VIII sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Human Coagulation Factor VIII Introduction
1.2 Market Analysis by Type
1.2.1 Recombinant Factor VIII
1.2.2 Plasma-derived Factor VIII
1.3 Market Analysis by Applications
1.3.1 Hemophilia A
1.3.2 Spontanous / Trauma
1.3.3 Surgical
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shire (Baxter)
2.1.1 Business Overview
2.1.2 Human Coagulation Factor VIII Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Human Coagulation Factor VIII Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 CSL
2.3.1 Business Overview
2.3.2 Human Coagulation Factor VIII Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CSL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Human Coagulation Factor VIII Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Grifols
2.5.1 Business Overview
2.5.2 Human Coagulation Factor VIII Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Grifols Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Biogen
2.6.1 Business Overview
2.6.2 Human Coagulation Factor VIII Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biogen Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Octapharma
2.7.1 Business Overview
2.7.2 Human Coagulation Factor VIII Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Octapharma Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 NovoNordisk
2.8.1 Business Overview
2.8.2 Human Coagulation Factor VIII Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Greencross
2.9.1 Business Overview
2.9.2 Human Coagulation Factor VIII Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Greencross Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Kedrion
2.10.1 Business Overview
2.10.2 Human Coagulation Factor VIII Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Kedrion Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 BPL
2.11.1 Business Overview
2.11.2 Human Coagulation Factor VIII Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 BPL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Hualan Bio
2.12.1 Business Overview
2.12.2 Human Coagulation Factor VIII Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 RAAS
2.13.1 Business Overview
2.13.2 Human Coagulation Factor VIII Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 RAAS Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Human Coagulation Factor VIII Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Human Coagulation Factor VIII Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Human Coagulation Factor VIII Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Coagulation Factor VIII Manufacturer Market Share in 2018
3.3.2 Top 6 Human Coagulation Factor VIII Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Human Coagulation Factor VIII Market Analysis by Regions
4.1 Global Human Coagulation Factor VIII Sales, Revenue and Market Share by Regions
4.1.1 Global Human Coagulation Factor VIII Sales and Market Share by Regions (2014-2019)
4.1.2 Global Human Coagulation Factor VIII Revenue and Market Share by Regions (2014-2019)
4.2 North America Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
4.3 Europe Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
4.5 South America Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
5 North America Human Coagulation Factor VIII by Country
5.1 North America Human Coagulation Factor VIII Sales, Revenue and Market Share by Country
5.1.1 North America Human Coagulation Factor VIII Sales and Market Share by Country (2014-2019)
5.1.2 North America Human Coagulation Factor VIII Revenue and Market Share by Country (2014-2019)
5.2 United States Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
5.3 Canada Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
5.4 Mexico Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
6 Europe Human Coagulation Factor VIII by Country
6.1 Europe Human Coagulation Factor VIII Sales, Revenue and Market Share by Country
6.1.1 Europe Human Coagulation Factor VIII Sales and Market Share by Country (2014-2019)
6.1.2 Europe Human Coagulation Factor VIII Revenue and Market Share by Country (2014-2019)
6.2 Germany Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
6.3 UK Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
6.4 France Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
6.5 Russia Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
6.6 Italy Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
7 Asia-Pacific Human Coagulation Factor VIII by Country
7.1 Asia-Pacific Human Coagulation Factor VIII Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Human Coagulation Factor VIII Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Human Coagulation Factor VIII Revenue and Market Share by Country (2014-2019)
7.2 China Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
7.3 Japan Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
7.4 Korea Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
7.5 India Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
8 South America Human Coagulation Factor VIII by Country
8.1 South America Human Coagulation Factor VIII Sales, Revenue and Market Share by Country
8.1.1 South America Human Coagulation Factor VIII Sales and Market Share by Country (2014-2019)
8.1.2 South America Human Coagulation Factor VIII Revenue and Market Share by Country (2014-2019)
8.2 Brazil Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
8.3 Argentina Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
8.4 Colombia Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
9 Middle East and Africa Human Coagulation Factor VIII by Countries
9.1 Middle East and Africa Human Coagulation Factor VIII Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Human Coagulation Factor VIII Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Human Coagulation Factor VIII Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
9.3 Turkey Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
9.4 Egypt Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
9.5 Nigeria Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
9.6 South Africa Human Coagulation Factor VIII Sales and Growth Rate (2014-2019)
10 Global Human Coagulation Factor VIII Market Segment by Type
10.1 Global Human Coagulation Factor VIII Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Human Coagulation Factor VIII Sales and Market Share by Type (2014-2019)
10.1.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2014-2019)
10.2 Recombinant Factor VIII Sales Growth and Price
10.2.1 Global Recombinant Factor VIII Sales Growth (2014-2019)
10.2.2 Global Recombinant Factor VIII Price (2014-2019)
10.3 Plasma-derived Factor VIII Sales Growth and Price
10.3.1 Global Plasma-derived Factor VIII Sales Growth (2014-2019)
10.3.2 Global Plasma-derived Factor VIII Price (2014-2019)
11 Global Human Coagulation Factor VIII Market Segment by Application
11.1 Global Human Coagulation Factor VIII Sales Market Share by Application (2014-2019)
11.2 Hemophilia A Sales Growth (2014-2019)
11.3 Spontanous / Trauma Sales Growth (2014-2019)
11.4 Surgical Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Human Coagulation Factor VIII Market Forecast (2019-2024)
12.1 Global Human Coagulation Factor VIII Sales, Revenue and Growth Rate (2019-2024)
12.2 Human Coagulation Factor VIII Market Forecast by Regions (2019-2024)
12.2.1 North America Human Coagulation Factor VIII Market Forecast (2019-2024)
12.2.2 Europe Human Coagulation Factor VIII Market Forecast (2019-2024)
12.2.3 Asia-Pacific Human Coagulation Factor VIII Market Forecast (2019-2024)
12.2.4 South America Human Coagulation Factor VIII Market Forecast (2019-2024)
12.2.5 Middle East and Africa Human Coagulation Factor VIII Market Forecast (2019-2024)
12.3 Human Coagulation Factor VIII Market Forecast by Type (2019-2024)
12.3.1 Global Human Coagulation Factor VIII Sales Forecast by Type (2019-2024)
12.3.2 Global Human Coagulation Factor VIII Market Share Forecast by Type (2019-2024)
12.4 Human Coagulation Factor VIII Market Forecast by Application (2019-2024)
12.4.1 Global Human Coagulation Factor VIII Sales Forecast by Application (2019-2024)
12.4.2 Global Human Coagulation Factor VIII Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Human Coagulation Factor VIII Picture
Table Product Specifications of Human Coagulation Factor VIII
Figure Global Sales Market Share of Human Coagulation Factor VIII
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
